The vulnerable atherosclerotic plaque

Author： Suckling K.E.  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.3, Iss.1, 1998-06, pp. : 121-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 10, 2007-04 ,pp. : 1003-1012

Bentham Science Publishers

Access to resources Recommend Favorite

Agents that stabilise atherosclerotic plaque

By Chiong Jun R   Miller Alan B  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1681-1692

Informa Healthcare

Access to resources Recommend Favorite

Atherosclerotic Plaque Regression: Fact or Fiction?

By Shanmugam Nesan   Román-Rego Ana   Ong Peter   Kaski Juan  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 311-317

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin induces atherosclerotic plaque regression

By  

Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Biomarkers Associated with Vulnerable Atheromatous Plaque

By  

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2588-2596

Bentham Science Publishers

Access to resources Recommend Favorite